Determination of the Minimum Effective Dosages of Praziquantel, Albendazole, and Mebendazole Against Clonorchis Sinensis Infection in Rats
Open Access
- 1 October 2005
- journal article
- research article
- Published by Wiley in The Kaohsiung Journal of Medical Sciences
- Vol. 21 (10) , 448-451
- https://doi.org/10.1016/s1607-551x(09)70149-4
Abstract
In order to determine the minimum effective dosages of praziquantel, albendazole, and mebendazole against Clonorchis sinensis infection in Sprague‐Dawley rats, each rat was infected with 30 metacercariae and treated with one of three drugs. The rats were killed and examined 25 days after praziquantel treatment or 11 days after albendazole or mebendazole treatment. The minimum effective dosages were a single dose of praziquantel 375 mg/kg, albendazole 150 mg/kg, and mebendazole 150 mg/kg. Trials are required to determine whether these dosages are useful in the treatment of human clonorchiasis.Keywords
This publication has 4 references indexed in Scilit:
- The current pathobiology and chemotherapy of clonorchiasisThe Korean Journal of Parasitology, 1986
- Pharmacology of AnthelminticsPublished by Springer Nature ,1985
- Clinical evaluation of the therapeutic efficacy of praziquantel (Embay 8440) againstClonorchis sinensisinfection in manPathogens and Global Health, 1981
- Experimental study on the therapeutic effect of praziquente1(Embay 8440) in rats experimentally infected with Clonorchis sinensisThe Korean Journal of Parasitology, 1980